FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2927471413> ?p ?o ?g. }

• W2927471413 endingPage "272" @default.
• W2927471413 startingPage "272" @default.
• W2927471413 abstract "Background. High-flow nasal cannula (HFNC) oxygen is a non-invasive alternative to nasal continuous positive airway pressure (CPAP) therapy for infants and children requiring respiratory support. There is a paucity of data to support its use in children, with no published data from sub-Saharan Africa. Objectives. To describe the outcomes of and adverse events related to HFNC in the first year of its use in a level 2 (L2) general paediatric ward, and to compare these outcomes with those of a historical cohort when this intervention was unavailable. Methods. This retrospective descriptive study included children aged <13 years who received HFNC in the first 12 months after its introduction (HFNC-availability group, n =66). Demographic data, clinical characteristics and outcomes (death, treatment failure, length of HFNC and HFNC-related adverse events) were assessed. A comparative description of children who required transfer to level 3 (L3) for any form of respiratory support (other than the available standard low-flow oxygen) during the 12-month period prior to HFNC availability (pre-HFNC group, n =54) was made. All analyses were performed in the paediatric wards, New Somerset Hospital, Cape Town, South Africa. Outcomes were compared using standard descriptive and comparative statistics. Results. The median age of the cohort was 5 months (interquartile range (IQR) 1.9 - 14.6). Sixteen children (13.3%) were malnourished, 10 (8.3%) were HIV-infected, and 30 (25.0%) had been born prematurely. The most common diagnoses were pneumonia, bronchiolitis and asthma. Asthma, anaemia and cardiac abnormalities were the most prevalent underlying comorbidities. Two children died in each group. All 54 children in the pre-HFNC group were transferred to L3; 38 (70.4%) needed CPAP or invasive ventilation. In the HFNC-availability period, 85 children were assessed as needing more than standard low-flow oxygen therapy: of the 19 immediately transferred to L3, 17 (89.4%) received CPAP or invasive ventilation; of the 66 who received HFNC at L2, 16 (24.2%) subsequently required transfer to L3 for CPAP or invasive ventilation. The median duration of HFNC was 46.3 hours (IQR 19.5 - 93.5) overall, and it was 12 hours (IQR 4 - 28) and 58.5 hours (IQR 39.5 - 106) for those who failed or were successfully managed on HFNC, respectively. No HFNC-related serious adverse events were recorded. Conclusions. HFNC is a safe, effective, feasible option for non-invasive ventilation of children with respiratory illnesses in a resource-limited L2 setting. A greater proportion of children with lower respiratory tract infections in the HFNC-availability group than in the pre-HFNC group required support, but the intervention reduced the bed pressure on L3. Improved ways to identify HFNC failures would be beneficial." @default.
• W2927471413 created "2019-04-11" @default.
• W2927471413 creator A5044236098 @default.
• W2927471413 creator A5053411630 @default.
• W2927471413 creator A5053462844 @default.
• W2927471413 date "2019-03-29" @default.
• W2927471413 modified "2023-09-23" @default.
• W2927471413 title "A review of the use of high-flow nasal cannula oxygen therapy in hospitalised children at a regional hospital in the Cape Town Metro, South Africa" @default.
• W2927471413 doi "https://doi.org/10.7196/samj.2019.v109i4.13145" @default.
• W2927471413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31084694" @default.
• W2927471413 hasPublicationYear "2019" @default.
• W2927471413 type Work @default.
• W2927471413 sameAs 2927471413 @default.
• W2927471413 citedByCount "11" @default.
• W2927471413 countsByYear W29274714132020 @default.
• W2927471413 countsByYear W29274714132021 @default.
• W2927471413 countsByYear W29274714132022 @default.
• W2927471413 countsByYear W29274714132023 @default.
• W2927471413 crossrefType "journal-article" @default.
• W2927471413 hasAuthorship W2927471413A5044236098 @default.
• W2927471413 hasAuthorship W2927471413A5053411630 @default.
• W2927471413 hasAuthorship W2927471413A5053462844 @default.
• W2927471413 hasBestOaLocation W29274714131 @default.
• W2927471413 hasConcept C119060515 @default.
• W2927471413 hasConcept C126322002 @default.
• W2927471413 hasConcept C141071460 @default.
• W2927471413 hasConcept C187212893 @default.
• W2927471413 hasConcept C194828623 @default.
• W2927471413 hasConcept C197934379 @default.
• W2927471413 hasConcept C2775867611 @default.
• W2927471413 hasConcept C2776006263 @default.
• W2927471413 hasConcept C2776042228 @default.
• W2927471413 hasConcept C2776136866 @default.
• W2927471413 hasConcept C2778074680 @default.
• W2927471413 hasConcept C2778821649 @default.
• W2927471413 hasConcept C2779547634 @default.
• W2927471413 hasConcept C2780334268 @default.
• W2927471413 hasConcept C2780630273 @default.
• W2927471413 hasConcept C42219234 @default.
• W2927471413 hasConcept C534529494 @default.
• W2927471413 hasConcept C71924100 @default.
• W2927471413 hasConcept C72563966 @default.
• W2927471413 hasConceptScore W2927471413C119060515 @default.
• W2927471413 hasConceptScore W2927471413C126322002 @default.
• W2927471413 hasConceptScore W2927471413C141071460 @default.
• W2927471413 hasConceptScore W2927471413C187212893 @default.
• W2927471413 hasConceptScore W2927471413C194828623 @default.
• W2927471413 hasConceptScore W2927471413C197934379 @default.
• W2927471413 hasConceptScore W2927471413C2775867611 @default.
• W2927471413 hasConceptScore W2927471413C2776006263 @default.
• W2927471413 hasConceptScore W2927471413C2776042228 @default.
• W2927471413 hasConceptScore W2927471413C2776136866 @default.
• W2927471413 hasConceptScore W2927471413C2778074680 @default.
• W2927471413 hasConceptScore W2927471413C2778821649 @default.
• W2927471413 hasConceptScore W2927471413C2779547634 @default.
• W2927471413 hasConceptScore W2927471413C2780334268 @default.
• W2927471413 hasConceptScore W2927471413C2780630273 @default.
• W2927471413 hasConceptScore W2927471413C42219234 @default.
• W2927471413 hasConceptScore W2927471413C534529494 @default.
• W2927471413 hasConceptScore W2927471413C71924100 @default.
• W2927471413 hasConceptScore W2927471413C72563966 @default.
• W2927471413 hasIssue "4" @default.
• W2927471413 hasLocation W29274714131 @default.
• W2927471413 hasLocation W29274714132 @default.
• W2927471413 hasLocation W29274714133 @default.
• W2927471413 hasOpenAccess W2927471413 @default.
• W2927471413 hasPrimaryLocation W29274714131 @default.
• W2927471413 hasRelatedWork W1972532624 @default.
• W2927471413 hasRelatedWork W2076273030 @default.
• W2927471413 hasRelatedWork W2227167248 @default.
• W2927471413 hasRelatedWork W2791356514 @default.
• W2927471413 hasRelatedWork W2910941732 @default.
• W2927471413 hasRelatedWork W2982533762 @default.
• W2927471413 hasRelatedWork W2995998636 @default.
• W2927471413 hasRelatedWork W3016426445 @default.
• W2927471413 hasRelatedWork W3094722220 @default.
• W2927471413 hasRelatedWork W3122737797 @default.
• W2927471413 hasVolume "109" @default.
• W2927471413 isParatext "false" @default.
• W2927471413 isRetracted "false" @default.
• W2927471413 magId "2927471413" @default.
• W2927471413 workType "article" @default.